Evolent Health, Inc. (EVH)
USD 10.69
(7.44%)
USD 10.69
(7.44%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 531.68 Million USD | 43.11% |
| 2022 | 336.46 Million USD | 20.37% |
| 2021 | 279.53 Million USD | -24.86% |
| 2020 | 372.02 Million USD | -18.01% |
| 2019 | 453.73 Million USD | 29.33% |
| 2018 | 350.82 Million USD | 47.38% |
| 2017 | 238.03 Million USD | 33.79% |
| 2016 | 177.91 Million USD | 115.78% |
| 2015 | 82.45 Million USD | 426.59% |
| 2014 | -25.24 Million USD | -250.2% |
| 2013 | 16.8 Million USD | 0.71% |
| 2012 | 16.69 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 67.21 Million USD | -2.27% |
| 2024 Q1 | 68.77 Million USD | -38.06% |
| 2023 Q2 | 122.52 Million USD | 2.96% |
| 2023 Q4 | 111.03 Million USD | -13.91% |
| 2023 FY | 481.52 Million USD | 43.11% |
| 2023 Q3 | 128.97 Million USD | 5.26% |
| 2023 Q1 | 119 Million USD | 15.94% |
| 2022 FY | 336.46 Million USD | 20.37% |
| 2022 Q2 | 74.06 Million USD | 0.04% |
| 2022 Q3 | 85.71 Million USD | 15.73% |
| 2022 Q1 | 74.03 Million USD | -9.7% |
| 2022 Q4 | 102.64 Million USD | 19.75% |
| 2021 Q3 | 66.15 Million USD | 14.82% |
| 2021 Q4 | 81.99 Million USD | 23.95% |
| 2021 Q1 | 73.77 Million USD | -27.18% |
| 2021 Q2 | 57.61 Million USD | -21.91% |
| 2021 FY | 279.53 Million USD | -24.86% |
| 2020 Q3 | 91.77 Million USD | 8.7% |
| 2020 Q2 | 84.43 Million USD | -10.66% |
| 2020 FY | 372.02 Million USD | -18.01% |
| 2020 Q4 | 101.31 Million USD | 10.39% |
| 2020 Q1 | 94.5 Million USD | -5.07% |
| 2019 FY | 453.73 Million USD | 29.33% |
| 2019 Q1 | 126.86 Million USD | 31.71% |
| 2019 Q4 | 99.54 Million USD | -8.69% |
| 2019 Q3 | 109.01 Million USD | -7.85% |
| 2019 Q2 | 118.3 Million USD | -6.74% |
| 2018 FY | 350.82 Million USD | 47.38% |
| 2018 Q4 | 96.32 Million USD | 10.83% |
| 2018 Q2 | 85.86 Million USD | 5.01% |
| 2018 Q1 | 81.77 Million USD | 23.28% |
| 2018 Q3 | 86.91 Million USD | 1.22% |
| 2017 FY | 238.03 Million USD | 33.79% |
| 2017 Q4 | 66.32 Million USD | 23.86% |
| 2017 Q3 | 53.55 Million USD | -7.66% |
| 2017 Q2 | 57.99 Million USD | -3.61% |
| 2017 Q1 | 60.16 Million USD | -6.12% |
| 2016 Q1 | 35.46 Million USD | -0.09% |
| 2016 FY | 177.91 Million USD | 115.78% |
| 2016 Q4 | 64.08 Million USD | 52.07% |
| 2016 Q3 | 42.14 Million USD | 15.88% |
| 2016 Q2 | 36.36 Million USD | 2.54% |
| 2015 FY | 82.45 Million USD | 426.59% |
| 2015 Q2 | 14.06 Million USD | -53.01% |
| 2015 Q3 | 32.89 Million USD | 133.83% |
| 2015 Q4 | 35.49 Million USD | 7.93% |
| 2015 Q1 | 29.93 Million USD | 379.81% |
| 2014 Q3 | -3.16 Million USD | 46.67% |
| 2014 Q2 | -5.93 Million USD | -135.14% |
| 2014 Q4 | -10.69 Million USD | -237.8% |
| 2014 Q1 | 16.89 Million USD | -61.2% |
| 2014 FY | -25.24 Million USD | -250.2% |
| 2013 FY | 16.8 Million USD | 0.71% |
| 2013 Q4 | 43.55 Million USD | 0.0% |
| 2012 FY | 16.69 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Well Corporation | 786.9 Million USD | 32.434% |
| Doximity, Inc. | 260.87 Million USD | -103.807% |
| MultiPlan Corporation | 564.07 Million USD | 5.743% |
| Phreesia, Inc. | 369.84 Million USD | -43.759% |
| Teladoc Health, Inc. | 2.09 Billion USD | 74.572% |
| Veeva Systems Inc. | 1.25 Billion USD | 57.704% |